Articles On Avita Medical (ASX:AVH)

ASX healthcare stocks haven’t done so well as a collective over the past 12 months. The S&P/ASX 200 Health Care Index (ASX: XHJ) is down 8% over the past year. By comparison, the market benchmark S&P/ASX 200 Index (ASX: XJO) is u...

Weekly update on stockbroker recommendation, target price, and earnings forecast changes. By Mark Woodruff Guide: The FNArena database tabulates the views of eight major Australian and international stockbrokers: Citi, Bell Potter, Macquari...

An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now...

Brokers raise target prices for Avita Medical following second quarter results amidst anticipation of exciting prospects in the outlook period. -Avita Medical has beaten consensus three quarters in a row-FY24 guidance upgraded-Recell Go on...

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((AVH)) - Avita Medical ((BBN)) - Baby Bunting ((NCM)) - Newcrest Mining ((NWS)) - News Corp ((NCK)) - Nick Scali ((PLL)) - Piedmont Lithium ((REA)) - REA Group Check it...

ASX health stocks fall 1.82% in the past five days in line as broader markets rise slightly Resmed sinks after delivering a mixed quarterly result including margins contracting Weight loss drug frenzy drives global big pharma plays Nova No...

Futures suggest the ASX is set to open flat this morning, following news that US CPI data had risen for the first time in 13 months to 3.2 per cent. US stocks ended in the green on Wall Street, and on home soil, here are some ASX-listed...

Why do you invest in ASX shares? For many Australians, their end goal is to receive an income without working. It’s not such a crazy dream, though. It’s very realistic, in fact. For those who have managed to save up $50,000 so far, let’s e...

ASX health stocks fall 2.4% in the past five days in line with broader markets Mesoblast crashes more than 50% after US FDA rejects a key product  ImpediMed falls after calls for board spill with discontent following cap raise Healthcare...

The ASX was higher by around 2.5% in July The best sectors were Tech and Energy We look at the best and worst performing ASX stocks for the month For the month of July, most major indexes on the ASX rose by around 2.5%. Name % Change...

ASX health stocks up 1% in the past five days in line with broader markets Volpara records third quarter of positive cashflow following successful growth strategy Gut health a popular theme at 17th Bioshares Biotech Summit along with immun...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

ASX health stocks have fallen in the past five days in line with broader markets Mach7 wins a US$60 million Veterans contract – the most significant in its history Neuren completes recruitment for Phase II trial of NNZ-2591 in Phelan-McDer...

The S&P ASX 200 was up 1.76% in June, with large caps performing the best and small caps lagging blue chips The S&P/ASX 200 Materials was the best performing sector in June, up 4.8% coming back from April drop An ASX favourite lith...

Avita Medical receives US FDA premarket approval for its RECELL System to treat vitiligo Telix will buy UK medical device firm Lightpoint Medical and its radio-guided surgery business SENSEI Antisense in strong position with new CEO, forme...

ASX-listed life science companies report a new market capitalisation of $255 billion, with Arovella Therapeutic (ASX:ALA) and Avita Medical (ASX:AVH) topping return rankings for Q1 while Neuren...

Avita Medical’s (ASX:AVH) RECELL System was first approved in the U.S. for the treatment of severe burns in 2018 and prepares, produces, and delivers a regenerative cell suspension, Spray-On Skin Cells, using a small amount of a patient’s o...

Regenerative medicine company AVITA Medical (ASX:AVH) has announced that the US FDA has approved its application for the premarket approval of its RECELL System for the treatment of vitiligo.

AVITA Medical’s (AVH) skin re-pigmentation device gains tick of approval from the USA’s Food and Drug Administration (FDA) to treat patients with vitiligo RECELL is an FDA-approved device which transfers skin cells from pigmented skin to...

Avita Medical shares are down by 4.2% despite positive news as the company announces FDA approval of its breakthrough RECELL skin repair system for vitiligo patients. The post Avita Medical [ASX:AVH] Gains FDA Approval of RECELL Product for...

AVITA receives US FDA premarket approval for its RECELL System Living Cell falls after saying it will enact a temporary pause on pig herd facility Oneview Healthcare signs material deal with NYSE-listed Baxter   Regenerative medicine comp...

AVITA Medical (ASX: AVH) has achieved a 'breakthrough approval' with the US Food and Drug Administration (FDA) by gaining pre-market approval for its RECELL system to treat vitiligo, an autoimmune disease that causes discoloration of the sk...

Spray on skin technology first created in WA will now be used to assist vitiligo patients in the US.

The ASX to open flat today as Wall Street retreated on Friday A Bank of America analyst says current market looks more like 2000 or 2008 Ford says the US is “not quite yet ready” to compete with China in EVs   Australian shares are poised...

Austco Healthcare wins St Paul’s Hospital in Canada worth $7.4m Next Science announced a new CEO AVITA Medical and Genetic Signatures announce new CFOs   Digital health company Austco Healthcare (ASX:AHC) surged by as high as 30% this mor...

Sigma offers very competitive terms to win back Chemist Warehouse contract from Rival EBOS  Pacific Edge slumps ~60% after the US Medicare ended coverage for its Cxbladder test Avita Medical gets US FDA premarket approval for use of its RE...

It has been 30 years in the making, when Dr Fiona Wood and scientist Marie Stoner recognised the potential of tissue engineering to treat burns and a skin culture facility was borne. Their product evolved from cultural sheets of cultural ep...

AVITA Medical (AVH) gains FDA approval to launch its RECELL spray-on skin system to treat full-thickness skin defects This provides relief for a broad label of full-thickness skin defects, including degloving, surgical excision and skin...

ShareCafeTech and Real Estate weigh on market: ASX closes 0.26% lower by Peter Milios   At the closing bell, the S&P/ASX 200 was 0.26 per cent lower at 7,099.70. The drop was mainly driven by losses in the technology and real estate sec...

ShareCafeBond yields surge: ASX 0.09% lower at noon by Peter Milios   At noon, the S&P/ASX 200 is 0.09 per cent lower at 7,111.50, as certain sectors sensitive to interest rates declined, while commodity sectors saw gains due to rising...

Avita receives US FDA approval for RECELL Emyria and Antisense to progress trials Beamtree has won a key contract in Canada   Avita Medical (ASX:AVH) announced that the US FDA has signed off on a premarket approval (PMA) for the use of it...

ShareCafeStocks of the Hour: ICL, AVH, ANP                  Iceni Gold (ASX:ICL) has hit a high-grade vein at the Everleigh well in Western Australia. Technical Director David Nixon comments: “The high-grade rock chip results from the...

08 Jun 2023 - A snapshot of the stocks on the move featuring Iceni Gold (ASX:ICL), Avita Medical (ASX:AVH) and Antisense Therapeutics (ASX:ANP).

The AVITA Medical Inc (ASX: AVH) share price is on fire on Thursday. In morning trade, the ASX healthcare share was up as much as 20% to a 52-week high of $5.14. The AVITA share price has pulled back since then but remains up 14% at the ti...

Regenerative medicine company AVITA Medical (ASX:AVH) has announced that the US FDA has approved its premarket approval supplement for the use of the RECELL System to treat full-thickness skin defects.

ASX health stocks outperforming the broader market but remain flattish for week Several ASX health plays undertaking capital raising with more expected in H2 CY23 Micro-X successfully tests its Argus bomb detection unit opening door to US$...

ASX health stocks have fallen in the past five days in line with broader markets Volpara Health Technologies reports strong FY23 results, above Morgan’s expectations Pharmaxis reports positive trial results in potential breakthrough treatm...

By Mark Woodruff Guide: The FNArena database tabulates the views of eight major Australian and international stockbrokers: Citi, Bell Potter, Macquarie, Morgan Stanley, Morgans, Ord Minnett, Shaw and Partners and UBS. For the purpose of bro...

ASX health stocks rise in the past five days in line with broader markets Immutep  surges 46% after positive Phase 2 results into lung cancer Avita Medical falls 28% in past five days despite reporting “solid Q1 FY23” results Healthcare a...

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((ALL)) - Aristocrat Leisure ((AVH)) - Avita Medical ((IPL)) - Incitec Pivot ((JHX)) - James Hardie Industries ((NWS)) - News Corp ((NUF)) - Nufarm ((REA)) - REA Group ((S...

World Overnight SPI Overnight 7260.00 + 40.00 0.55% S&P ASX 200 7199.20 – 35.50 – 0.49% S&P500 4158.77 + 48.87 1.19% Nasdaq Comp 12500.57 + 157.51 1.28% DJIA 33420.77 + 408.63 1.24% S&P500 VIX 16.87 – 1.12 – 6.23%...

Brokers review first quarter results and pending regulatory approvals for Avita Medical. -Avita Medical awaits near-term regulatory approvals-Potential Recell launch in the US for soft tissue repair-Early 2024 launch of Recell Go will reduc...

World Overnight SPI Overnight 7217.00 – 37.00 – 0.51% S&P ASX 200 7234.70 – 32.40 – 0.45% S&P500 4109.90 – 26.38 – 0.64% Nasdaq Comp 12343.05 – 22.16 – 0.18% DJIA 33012.14 – 336.46 – 1.01% S&P500 VIX 17.99 + 0.87 5...

Regenerative medical company AVITA Medical (ASX:AVH) has reported a 40 per cent increase in revenue for the first quarter of 2023.

After a feeble start, the benchmark has rallied to close at +0.1% Newcrest and Newmont shake hands on Australia’s biggest goldie takeover Westar Resources shines bright with a 47% price hike   As far as days on the ASX go, that definitely...

For the first day of the trading week, the market closed in the green at 7,267.10 points. In the Green Gold producer, Silver Lake Resources’ (SLR) price made a rebound, amid a battle to takeover fellow gold producer St Barbara’s Leo...

Stock in tiny lithium hopeful Lithium Energy Ltd (ASX: LEL) took off earlier today before plunging into the red on news of a massive find at the company’s Solaroz Brine Project. The project is located in Argentina, right next door to All...

It’s been a fairly lacklustre start to the trading week for most ASX shares so far this Monday. At the time of writing, the All Ordinaries Index (ASX: XAO) has fallen by 0.21%. But let’s talk about the plunging Avita Medical Inc. (ASX: AVH...

The Tyro Payments Ltd (ASX: TYR) share price has followed the All Ordinaries Index (ASX: XAO) lower today despite the payment solutions provider upgrading its full-year guidance. The upgrade came on the back of a strong 10-month period and...